At IMBdx, our people are our most valuable asset. We are a team with expertise in NGS laboratory experiments
and clinical NGS data analysis.
We have different cultural and educational backgrounds, but our goal is the same:
Changing the way cancer is diagnosed, treated, and viewed.
-
Tae-You Kim MD/PhD
Co-Founder & CEO
- Medical oncologist at Seoul National Univ. Hospital
- Post-doc at William Kaelin Lab, Harvard Univ.
- Chairman, Korean Cancer Asso.
- Post-doc, Harvard Univ. (William Kaelin Lab)
-
Duhee Bang PhD
Co-Founder & Chief Scientific Advisor
- Professor of Chemistry, Yonsei Univ.
- Damon Runyon Foundation Fellow, George Church Lab, Harvard Univ.
- PhD in Chemistry, Univ. of Chicago
-
Peter Moon MBA
Co-Founder & CEO
- MBA, University of Dublin
- Prev. senior roles at SK Innovation and Hyosung Industries
-
Hwang-Phill Kim PhD
Chief Business Officer
- Former Assoc. Prof., Dept. of Molecular Medicine, SNU
- Former Asst. Prof., SNU Cancer Research Institute
-
Su Yeon Kim PhD
Chief Informatics Officer
- PhD in Statistics, Univ. of Chicago
- Prev. Associate Director of Bioinformatics, Veracyte
- Postdoc, UC Berkeley
-
Sang-Hyun Song PhD
Chief Technology Officer
- Prev. Prof., Dept. of Molecular Medicine, SNU
- Prev. Asst. Prof., SNU Cancer Research Institute
- Post-doc at Dr. Dean Lab. (NIH/NIDDK)
- PhD in Tumor Biology, SNU
-
Yoojoo Lim MD
Director of CDx
- Prev. medical oncologist at Seoul National Univ. Hospital
- Former Asst. Prof., Seoul National Univ. Hospital